[{"NetIncomeLossConverted_4_FY_USD":3806267000.0,"NetIncomeLossConverted_1_FY_USD":839200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":29768000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":575328000.0,"EarningsPerShareDiluted_4_FY_USD":126.2,"EarningsPerShareDiluted_1_FY_USD":27.81,"RevenuesConverted_1_FY_USD":789800000.0,"StockholdersEquity_0_FY_USD":9879940000.0,"RevenuesConverted_4_FY_USD":2545600000.0,"Assets_0_FY_USD":12972618000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":30160000.0,"EarningsPerShareBasic_4_FY_USD":127.86,"EarningsPerShareBasic_1_FY_USD":28.13,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20210216"}]